Genmab A (GMAB) Amortizatization of Intangibles (2024 - 2026)

Genmab A (GMAB) reported Amortizatization of Intangibles of $13.0 million for Q1 2026, up 225.0% on a YoY basis from $4.0 million in Q1 2025, and up 18.18% quarter-over-quarter from $11.0 million in Q3 2025.

Genmab A (GMAB) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends

Genmab A has reported Amortizatization of Intangibles for 3 years, with the latest figure at $13.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Amortizatization of Intangibles rose 225.0% year-over-year to $13.0 million; the trailing twelve-month figure through Mar 2026 stood at $35.0 million (up 105.88% YoY), and the FY2025 full-year result was $16.0 million, up 45.45% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $13.0 million, up from $11.0 million in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $13.0 million in Q1 2026, with the low at $2.0 million in Q1 2024.
  • Historically, Amortizatization of Intangibles has averaged $6.9 million across 3 years, with a median of $7.0 million in 2024.
  • Annual changes were most pronounced in 2025 — Amortizatization of Intangibles jumped 57.14% — and 2026, when it jumped 225.0%.
  • Genmab A's Amortizatization of Intangibles stood at $7.0 million in 2024, then jumped by 57.14% to $11.0 million in 2025, then grew by 18.18% to $13.0 million in 2026.
  • The last three Amortizatization of Intangibles figures came in at $13.0 million (Q1 2026), $11.0 million (Q3 2025), and $7.0 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 13,267.00
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -
10 Genmab A 48.34 Bn 46.82 Bn 831.00 Mn 13.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 13.00 Mn
Mar 31, 2026 13.00 Mn
Sep 30, 2025 11.00 Mn
Sep 30, 2025 11.00 Mn
Jun 30, 2025 7.00 Mn
Jun 30, 2025 7.00 Mn
Mar 31, 2025 4.00 Mn
Mar 31, 2025 4.00 Mn
Sep 30, 2024 7.00 Mn
Sep 30, 2024 7.00 Mn
Jun 30, 2024 4.00 Mn
Jun 30, 2024 4.00 Mn
Mar 31, 2024 2.00 Mn
Mar 31, 2024 2.00 Mn